文献速递前列腺癌

前列腺特异性膜抗原靶向前列腺癌原发灶正电子发射断层成像:用全mount病理评估准确性

Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology.
PubMed 文献 · J Urol · 2019-08-20

这项前瞻性观察研究纳入根治性前列腺切除术患者,术前行[68Ga]Ga-PSMA-11 PET/CT或PET/MRI并行离体标本PET,用全mount病理进行病灶及病灶内分析。共15例患者发现30个癌灶,PSMA-PET检出全部原发/索引病灶及11个继发病灶中的8个(82%),所有Grade Group 3-5病灶均被检出,3个漏诊继发病灶小且pattern 4比例低。

要点

  • PSMA-PET检出100%原发/索引病灶和8/11(82%)继发病灶。
  • 所有Grade Group 3-5病灶均检出,Grade Group 2检出12/15。
  • 3个漏诊继发病灶pattern 4占比≤10%,Gleason pattern 4/5体积<0.1 cm3。

核心结论

  • 本研究PSMA-PET检出100%原发/索引病灶,3个漏诊继发病灶小且pattern 4比例低,作者认为需进一步研究以更好理解临床显著前列腺癌的定义。

研究设计与样本

  • 前瞻性观察研究,纳入接受根治性前列腺切除术的患者,术前行[68Ga]Ga-PSMA-11 PET/CT或PET/MRI,术中给予[68Ga]Ga-PSMA-11行离体标本PET,全mount病理进行病灶及病灶内分析。
  • 全mount分析共15例患者发现30个癌灶,Grade Group 1、2、3、4、5分别为4、15、4、1和6个。

主要发现

  • PSMA-PET检出100%原发/索引病灶和8/11(82%)继发病灶。
  • 所有Grade Group 3-5病灶均检出,Grade Group 2检出12/15。
  • Grade Group 2与3-5相比病灶大小相似(p=0.48),但标准化摄取值较低(5.3 vs 7.9,p=0.03)。
  • 3个漏诊病灶pattern 4占比≤10%,Gleason pattern 4/5体积<0.1 cm3。

临床怎么用

  • 原文结论未据此给出临床推荐,仅指出需进一步研究以更好理解临床显著前列腺癌的定义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated which lesions are detected and missed on [68Ga]Ga-PSMA (prostate specific membrane antigen)-11 positron emission tomography in patients with primary prostate cancer. MATERIALS AND METHODS: Patients undergoing radical prostatectomy were enrolled in this prospective observational study. Patients underwent [68Ga]Ga-PSMA-11 positron emission tomography/computerized tomography or positron emission tomography/magnetic resonance imaging prior to surgery and received a dose of [68Ga]Ga-PSMA-11 intraoperatively for positron emission tomography of extirpated specimens. Whole mount pathology was performed with lesion and intralesion based analysis to determine the characteristics of lesions detected or not detected by PSMA positron emission tomography. Lesion volume was determined by planimetry and clinically significant lesion volume was calculated as lesion volume × fraction pattern 4/5. RESULTS: On whole mount analysis 30 cancerous lesions were found in a total of 15 patients, including 4, 15, 4, 1 and 6 which were Grade Group 1, 2, 3, 4 and 5, respectively. PSMA-positron emission tomography detected 100% of primary/index lesions and 8 of 11 (82%) secondary lesions. All Grade Group 3-5 lesions were detected vs 12 of 15 Grade Group 2 lesions. When comparing Grade Group 2 vs 3-5, lesion size was similar (p=0.48) but the standardized uptake value was lower for Grade Group 2 vs 3-5 (5.3 vs 7.9, p=0.03). The 3 missed lesions showed 10% or less of pattern 4 and a Gleason pattern 4/5 volume of less than 0.1 cm3. CONCLUSIONS: PSMA positron emission tomography detected 100% of primary/index lesions in this study. The 3 missed secondary lesions were small and had a low percent of pattern 4. This argues for further study to better understand what defines clinically significant prostate cancer, which would assist in determining whether small lesions that become challenging to detect by [68Ga]Ga-PSMA-11 positron emission tomography confer a risk to the patient.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Bahler CD, Green M, Hutchins GD, et al. Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology. J Urol. 2019. PMID: 31430234. doi:10.1097/JU.0000000000000501

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。